Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

116.25
Delayed Data
As of Jul 22
 +0.24 / +0.21%
Today’s Change
67.81
Today|||52-Week Range
119.90
+28.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line8.9M7.7M10.6M11.0M
 
 
 
 
 
Depreciation663.0K689.0K862.0K1.1M
 
 
 
 
 
Total Other Cash Flow5.1M11.3M7.1M5.1M
 
 
 
 
 
Funds From Operations20.5M24.7M25.1M22.1M
 
 
 
 
 
Funds From/For Other Operating Expenses9.5M6.8M-277.0K-466.0K
 
 
 
 
 
Net Cash Flow - Operating Activities10.9M17.9M25.4M22.6M
 
 
 
 
 
 
InvestingIncrease In Investments-42.7M-57.1M-90.6M-71.4M
 
 
 
 
 
Decrease In Investments50.3M51.2M68.7M49.4M
 
 
 
 
 
Capital Expenditures-1.9M-1.6M-4.5M-7.7M
 
 
 
 
 
Net Cash Flow Investing5.7M-7.5M-26.4M-29.6M
 
 
 
 
 
 
FinancingShort Term Borrowings----0.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale4.6M3.8M266.0K2.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing81.0K302.0K105.0K3.1M
 
 
 
 
 
Other Uses - Financing3.5M345.0K98.0K3.4M
 
 
 
 
 
Net Cash Flow - Financing1.2M3.8M273.0K1.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash167.0K-280.0K-485.0K183.0K
 
 
 
 
 
 
Net Change In Cash17.9M14.3M-710.0K-5.2M